Navigation Links
Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium
Date:10/30/2009

David Ansell, Chicago Breast Cancer Quality Consortium steering committee member and chief medical officer, Rush University Medical Center. "We all know how we can improve ourselves, but it's only when we start sharing information, warts and all, across institutions that we can have regional impact on quality and safety."

Historically, healthcare providers have been reluctant to share quality data that may show quality deficits because of fear of legal discovery. To address this issue, Congress passed the Patient Safety and Quality Improvement Act of 2005. This law created a new designation of patient safety organization that receives special federal confidentiality protections to encourage the sharing of such sensitive data.

The mission of the Chicago Breast Cancer Quality Consortium is to bring healthcare providers together to share, in a confidential manner, quality data in the area of breast cancer screening and treatment in order to identify quality deficits and implement strategies to eliminate those deficits. The Consortium's goal is to eliminate the racial health disparity in breast cancer deaths in Chicago.

Studies conducted by the Sinai Urban Health Institute have shown that African-American women in Chicago are more than twice as likely to die of breast cancer compared to Caucasian women. The mortality rate for African American women is a shocking 116 percent higher than that of white women, compared to a 47 percent disparity nationally and 21 percent in New York.

"We already know that differences exist across institutions in the quality of breast cancer screenings and diagnosis, as well as in the timeliness of screenings and treatment," said Marie Rule Gilliam, MHSA, Executive Director of the Task Force. "The medical community has now come together to track and compare quality measures in these areas, so that women in Chicago can receive the best possible diagnosis
'/>"/>

SOURCE Metropolitan Chicago Breast Cancer Task Force
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Air Products Sells Three U.S. Healthcare Businesses to Landauer-Metropolitan
2. YMCA of Metropolitan Chicago CEO Cole Announces Retirement
3. Metropolitan Nashville Hospital Authority Completes Voice and Data Upgrade with tw telecoms Network Solutions
4. Metropolitan Jewish Health System Awards Electronic Medical Records Contract to SigmaCare(R)
5. Care Improvement Plus Recognized with Metropolitan Partnership in Aging Award
6. Metropolitan Health Networks Reports 2008 Second Quarter Results
7. Metropolitan Health Plan Announces Senior Management Appointments
8. Doctor Diabetic Supply Awarded by Medicare to Provide Mail-Order Diabetic Testing Supplies in 10 Metropolitan Areas
9. A New Year, A New Opportunity: Metropolitan Community Church Leaders Urge Faith Leaders to Address HIV and Crystal Meth Use Among LGBT Youth
10. Metropolitan Hosts Informational Meetings in Nassau County
11. Warady & Davis LLP Named One of 'Top 50 Employers for Generation Y Chicago'

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...d when taking sedatives, antidepressants, benzodia...24 (HealthDay News) -- Seniors who take antidepres...s may be at increased risk for falls, a new review...ished studies that included a total of 79,081 part... classes of drugs: high blood pressure medicines; ...
(Date:11/24/2009)...CLARA,Calif.,Nov.24/PRNewswire/--AgitoNetworks,Inc...isemobility,todayannouncedthatitwashonoredintheEve...oRoamAnywhereMobilityRouterv3.0.EverythingChannel,...haveintroducednewsolutionsthatdriveadvancesthrough...TestCenterreviewedhundredsofapplicationsforthe2009...
(Date:11/24/2009)...NGTON,Nov.24/PRNewswire/--TheUnionLaborLifeInsuran...alignedwithVSP(®),()thenation,slargestvisionb...nsuranceproductstounions,uniontrustfunds,unionempl...sspointsofferingservicesincludingcomprehensiveeyee...rstandhowimportantqualityeyecareis,"statedBruceSmi...
(Date:11/24/2009)...hat quitting improves heart prospects, but cancer ...hDay News) -- A new study offers yet more proof th...eart disease and cancer. , Researchers followed...ers, formers smokers and nonsmokers for three year...es more likely to die of cancer, 2.26 times more l...
(Date:11/24/2009)...s an example, study finds no added use but higher ...ws) -- Direct-to-consumer drug ads may contribute ... that examined sales of the widely used antiplatel... data from 1999 to 2005 for 27 state Medicaid prog... clopidogrel did not increase people,s use of the ...
Breaking Medicine News(10 mins):Health News:Some Prescription Meds May Raise Seniors' Risks of Falling 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 3Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Smokers Double Their Risk for Heart Disease 2Health News:Advertising to Consumers May Raise Drug Prices 2
...iversity proves that organic farmers who let their...r quality milk. , The Nafferton Ecological Farmin...arms in the UK produce milk which contains signifi...the beneficial fats in particular conjugated lino...
...owth and product development, AUSTIN, Texas, May ...ness intelligence software to hospitals, health sy...s acquired by The Advisory,Board Company (Nasdaq: ...atform and develop new products., Crimson,s busin...
...spital staff to overcome potential for human ... LENEXA, Kan., May 27 Mediware Information,Syste...provider of,ClosedLoop(TM) clinical systems for bl...nting with Mediware,s HCLL blood,management softwa...
...,Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced ...om Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY ) ... announced transaction,between Takeda Pharmaceutic...her emphasizes the value of Isis, innovation,and t...
...ser to that of roses or bananas? Weizmann Institut...s) by showing for the first time that smells can b... odors determined. Their findings, which appeared ...igitized and transferred via computer in the futur...
...wire-FirstCall/ -- Lotus Pharmaceuticals,Inc. (OTC... a,pharmaceutical company in the People,s Republic...nduct a conference call at 10:00 a.m. Eastern Time...uticals, will be Mr. Adam Wasserman, Chief Financi...
Other Medicine News:Health News:UK's organic cows are cream of the crop 2Health News:UK's organic cows are cream of the crop 3Health News:Crimson Announces Acquisition by The Advisory Board Company 2Health News:All Children's Hospital Achieves ISBT 128 Compliance With Mediware's HCLL Blood Bank System 2Health News:All Children's Hospital Achieves ISBT 128 Compliance With Mediware's HCLL Blood Bank System 3Health News:Isis to Receive $4.6 Million From Alnylam 2Health News:Isis to Receive $4.6 Million From Alnylam 3Health News:Weizmann Institute scientists produce the first smell map 2Health News:Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 3
(Date:11/24/2009)...LEIGH,N.C.,Nov.24/PRNewswire/--PharmaceuticalInsti...sforthepharmaceuticalandbiotechindustry,todayannou...lace .Thenew HospitalMarketplace e-courseisthenewe...TM) series,acomprehensiveseriesofe-coursesdesigned...ketsknowledgeforcommercialprofessionals. ,, The...
(Date:11/24/2009)...SSISSAUGA,Ontario,Nov.24/PRNewswire-FirstCall/--Ca...eloperoftechnologyandproductstargetingtheimmunoass...mieS.A.S.("MerckChimie")isprogressingtothenextphas...ilvercoatedparamagneticBeads("Beads"). ,, Perth...syear,CardioGenicssuppliedMerckChimiewithitspropri...
(Date:11/24/2009)...NDIEGO,Nov.24/PRNewswire-FirstCall/--NeurocrineBio...nGorman,PresidentandChiefExecutiveOfficerofNeurocr...rJaffrayHealthCareConferenceinNewYork. ,, Theli...30p.m.EasternTime(ET)/1:30p.m.PacificTime(PT).Thep...ssedontheCompany,swebsiteat http://www.neurocrine....
Breaking Medicine Technology:Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 32009 CMA Medal of Service 54338 12009 CMA Medal of Service 54338 22009 CMA Medal of Service 54338 3OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma 54336 1OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma 54336 2OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma 54336 3Nicholas Vogelzang MD Joins US Oncology Research Network via Comprehensive Cancer Centers of Nevada 54335 1Nicholas Vogelzang MD Joins US Oncology Research Network via Comprehensive Cancer Centers of Nevada 54335 2Nicholas Vogelzang MD Joins US Oncology Research Network via Comprehensive Cancer Centers of Nevada 54335 3Nicholas Vogelzang MD Joins US Oncology Research Network via Comprehensive Cancer Centers of Nevada 54335 4
...Commences Phase I Clinical Trial of Proprietary si...Renal Failure, FREMONT, Calif., Nov. 19 Quark Ph...tical company focused on discovering and,developin...nced today that,it has commenced systemic dosing i...i-5, a siRNA compound discovered and developed by ...
...SAN DIEGO, Nov. 16 ADVENTRX Pharmaceuticals,Inc. ...m its,marketing-enabling clinical study of ANX-530...ce, the primary endpoint of the study, was,observe...product, in,patients with advanced cancer potentia...nstrated by a statistical comparison of both the a...
Other Medicine Technology:Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans 2Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans 3Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans 4ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study 2ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study 3ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study 4ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study 5
...re highly accurate in detecting the presence of dr... by GC/MS testing. This assay provides a prelimina... (such as GC/MS) must be used in order to obtain a... applied to any drug of abuse test result, particu...
...cker version of TheraTears that is perfect for nig...tective film during the day. Because TheraTears Li...out a preservative so that unlike preserved gels, ...vative-induced irritation. And because of its pate...
...t Drops improve comfort on contact lens insertion ...s from your disinfecting system or from its bliste...place one or two drops of TheraTears on the lens r...go in much easier and much more comfortably. Then,...
...epared by coating the suture with a mixture of a c...yl lactylate. POLYSORB sutures are colored violet ...ed. POLYSORB™ sutures meet all requirements ...) and the European Pharmacopeia (EP) except for mi...
Medicine Products: